Other secondary osteonecrosis, right finger(s)
ICD-10 M87.344 is a billable code used to indicate a diagnosis of other secondary osteonecrosis, right finger(s).
M87.344 refers to a specific type of osteonecrosis that occurs in the right finger(s) as a result of secondary factors, such as trauma, corticosteroid use, or underlying medical conditions like sickle cell disease or systemic lupus erythematosus. Osteonecrosis, also known as avascular necrosis, is characterized by the death of bone tissue due to a lack of blood supply. In the case of secondary osteonecrosis, the condition is not idiopathic but rather a consequence of other medical issues or external factors. Patients may present with pain, swelling, and limited range of motion in the affected finger(s). Diagnosis typically involves imaging studies such as X-rays or MRI to assess the extent of bone damage. Treatment options may include conservative management with pain relief, physical therapy, or surgical interventions such as core decompression or joint replacement, depending on the severity of the condition. Understanding the underlying cause of the osteonecrosis is crucial for effective management and prevention of further complications.
Detailed history of the patient's condition, imaging results, and treatment plans.
Patients with a history of corticosteroid use presenting with finger pain.
Ensure accurate documentation of the specific finger(s) affected and any underlying conditions contributing to osteonecrosis.
Comprehensive assessment of systemic conditions that may lead to osteonecrosis.
Patients with autoimmune diseases presenting with joint pain and swelling.
Document the relationship between systemic disease and osteonecrosis to support coding.
Used when treating osteonecrosis with joint injections.
Document the indication for the procedure and the specific joint involved.
Orthopedic specialists should ensure proper coding for joint injections related to osteonecrosis.
Common causes include corticosteroid use, trauma, alcohol abuse, and certain medical conditions such as sickle cell disease and systemic lupus erythematosus.
